Clinical Trials Directory

Trials / Completed

CompletedNCT04426383

Evaluation of a TDM Program for Intensive Care Patients in the Cerebrospinal Fluid

Evaluation of a TDM Program for Intensive Care Patients in the Cerebrospinal

Status
Completed
Phase
Study type
Observational
Enrollment
32 (actual)
Sponsor
Ludwig-Maximilians - University of Munich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Therapeutic drug monitoring of antibiotics in critically ill patients is a present research topic of the last ten years. Research results have shown subtherapeutic blood concentrations in those patients. However, the amount of antibiotics in the cerebrospinal fluid (CSF) in patients with ventriculitis or meningitis is still unclear. This study is a prospective study to evaluate the concentration of different antibiotics in the CSF in patients with an external ventricular drainage compared to antibiotic blood concentration.

Detailed description

Bacterial infections are still associated with a high mortality in intensive care unit patients. Especially patients diagnosed with ventriculitis caused by a bacterial infection have a bad outcome. Therefore, antibiotic therapy is the only causal opportunity to treat those infections. However, there are many chances in pharmacokinetic and -dynamic in critically ill patients with unpredictable antibiotic concentrations. Furthermore, it is important that the concentration in the blood as well as in the effect-compartment "CSF" is sufficient. Less data of the last years describe antibiotic concentrations in the CSF and show subtherapeutic levels, which is endangering for the therapeutic success. The introduced study is a prospective, observational study that analyses antibiotic concentrations in CSF in critically ill patients. The distribution between CSF and blood will be evaluated by comparing these two compartments.

Conditions

Timeline

Start date
2020-06-01
Primary completion
2022-01-31
Completion
2022-05-01
First posted
2020-06-11
Last updated
2022-06-01

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04426383. Inclusion in this directory is not an endorsement.